What is BioCryst Pharmaceuticals's restructuring reserve?

BioCryst Pharmaceuticals (BCRX) reported restructuring reserve of $596K in Q1 2026.

What does restructuring reserve mean?

This represents the estimated liability for costs associated with formal restructuring plans, such as severance, facility closures, or asset impairments. It reflects management's commitment to operational efficiency and strategic realignment. These reserves are drawn down as the restructuring activities are executed.

BioCryst Pharmaceuticals BCRX Restructuring Reserve

Restructuring Reserve at other companies

ABM IndustriesABM

$3.6M—

Gates Industrial CorporationGTES

$12.7M+338%

Celanese CorporationCE

$34M-20.9%

Resideo Technologies, Inc.REZI

$21M—

BioCryst PharmaceuticalsBCRX

$596K—

Travel + LeisureTNL

$18M+5.9%

Other financials

Income statement

See full

Revenue$156.4M+7.5%

Gross profit$151.0M+7.1%

Operating income-$701.6M-3,405%

Net income-$721.8M-2,255,763%

EPS (diluted)-$2.98—

Balance sheet

See full

Cash & equivalents$173.4M+62.2%

Total debt$411.8M+24.7%

Total equity-$553.8M-22.6%

Total assets$465.1M-3.1%

Cash flow

See full

Operating cash flow-$61.8M-125%

CapEx$403.0K+182%

Free cash flow-$62.2M-125%

Valuation

See full

Market cap$2.37B+52.3%

Enterprise value$2.6B+46.7%

P/S2.7×-0.4×

Profitability

See full

Gross margin97.8%+0.8pp

Operating margin-43.1%-49.7pp

Net margin-51.7%-69.7pp

FCF margin35%—

Returns & leverage

See full

Return on equity-882.8%—

Debt / equity0.1×—

Current ratio1.9×-1.0×

Where this comes from

Reported directly by BioCryst Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:RestructuringReserve.

The official record: BioCryst Pharmaceuticals’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about BioCryst Pharmaceuticals's restructuring reserve.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is BioCryst Pharmaceuticals's restructuring reserve?: BioCryst Pharmaceuticals (BCRX) reported restructuring reserve of $596K in Q1 2026.
What does restructuring reserve mean?: This represents the estimated liability for costs associated with formal restructuring plans, such as severance, facility closures, or asset impairments. It reflects management's commitment to operational efficiency and strategic realignment. These reserves are drawn down as the restructuring activities are executed.